Faster, better, together: Biopharma collaboration trends in the pandemic, and the future of medicine
The strategic collaborations born out of the efforts to help address the COVID-19 pandemic have offered a wealth of insight into how the biopharma industry will continue to change in the years to come. Companies across the supply chain - from raw materials and technology suppliers to biomanufacturers - view collaboration as a critical strategy to advancing biologics research, scale-up and manufacturing for all biologics development.
Watch Avantor´s and C&EN´s webinar featuring Avantor subject matter experts and guest industry speakers, discussing the benefits of partnership and collaboration.
This webinar event, hosted by C&EN, took place October 27, 2021
Presented by:
 |
|
Justin Moran, PhD, Executive Director, Head of Early Bioprocess Development, Pfizer Vaccines
The Impact of a Pandemic on Process Development |
| |
 |
|
Nandu Deorkar, Ph.D., MBA, Senior Vice President, Research & Development – Biopharma Production, Avantor
He is responsible for innovation strategy and planning, and execution of new products and technology development. During his more than 25-year career in research & development, Dr. Deorkar has been leading teams working on various aspects of upstream and downstream bioprocessing, single use systems, chemical/polymer R&D, drug development, formulation, drug delivery technologies, process development, and technology transfer. He has published more than 30 articles and holds more than 20 patents. Dr. Deorkar received Ph.D. from Indian Institute of Technology, Mumbai, India and MBA in Marketing from Fairleigh Dickinson University, Madison, NJ, USA. |
| |
 |
|
Jennifer Grossman, PhD, Business Development Manager, Pilot Bioproduction Facility, Walter Reed Army Institute of Research
Lessons on flexibility and scaling-up fast: how the biopharmaceutical industry is preparing to face the next pandemic |
| |
 |
|
Claudia Berrón, MBA, Senior Vice President, Avantor Clinical Services, Avantor
The impact of decentralization and digitization on clinical trial logistics, kits, and sample management |
| |
|
|
 |
|
Pranav Vengsarkar, PhD, Manager, Process Development, Research Biopharma Production, Avantor
Enhanced raw material delivery strategies: Debottlenecking of buffer and media preparation in mAbs and novel therapeutics |
